Sex dependence of human intracranial gliomata. by Hopewell, J. W. et al.
Br. J. Cancer (1976) 34, 666
SEX DEPENDENCE OF HUMAN INTRACRANIAL
GLIOMATA
J. W. HOPEWELL, D. N. EDWARDS* AND G. WIERNIK
From the Research Institute, Churchill Hospital, Oxford, and the *Clinical Research Unit,
M1ers8ey Regional Centre for Radiotherapy and Oncology, Clatterbridge Hospital, illerseyside
Received 18 February 1976 Accepted 16 July 1976
Summary.-The age and sex distribution of 1223 cases of intracranial gliomata,
diagnosed in the geographical area covered by the Mersey Regional Cancer Registry
over the period 1961-70, are analysed. In children and adults, the intracranial
gliomata predominates in males, the tumour incidence figures indicating a ratio of
3: 2. For young adults, the tumour incidence increases withage and is approximately
the same in males and females. It is not until the age group 45-49 years is reached
that the tumour incidence in males is higher. The peak tumour incidence occurs at
the same age in both sexes (60-64 years) and thereafter incidence declines with age.
These results are compared with previously published human data, and with the
findings of experimental studies in the rat. Factors including naturally occurring
changes in the hormone levels are discussed, in an attempt to explain the observed
age-related sex differences.
CENTRAL nervous system tumours of
neuroectodermal origin, the gliomata,
form approximately 20% of all human
malignancies (Willis, 1953). Although
they represent only a small proportion of
tumours in adults, they form the second
most common group oftumours in children
(Sheline, 1975). The sex distribution of
the gliomata, with the predominance of
tumours in males, in both children and
adults, has already been reported (Bodian
and Lawson, 1952; Penman and Smith,
1954). Experimental studies in the rat,
in which carcinogens were implanted
intracerebrally, have suggested glioma
induction to be dependent on a common
precursor of the oestrogens and testo-
sterone (Hopewell, 1975). It seems likely
that the observed sex difference in human
gliomata might be explained by the
naturally occurring variation in hormone
levelswith age, in both males and females.
In the recent literature no information
exists to enable the age- and sex-related
incidence of intracranial gliomata to be
determined with any certainty. Existing
studies have examined only a very limited
number of cases (Guomundsson, 1970;
Percy et al., 1972) or examined the com-
bined age-related incidence of all brain
tumours, including meningiomas and be-
nign tumours (Cohen and Modan, 1968;
Waterhouse, 1974). The gliomata may
represent only 38-58% of all intracranial
tumours (Guomundsson, 1970). The pur-
pose of the present study is to analyse the
sex differences for intracranial gliomata
incidence with respect to age, in a large
well-documented series of cases.
MATERIAL
The 1223 cases of intracranial gliomata
included in this report were those diagnosed
in the Liverpool Regional Hospital Board
area and the 5 northern counties of Wales,
over the period 1961-70. The figures were
supplied by the Mersey Regional Cancer
Registry, who cover this geographical area.
In the majority of these cases (820) the
diagnosis was confirmed by subsequent
histology, the remainder (403) being identified
by clinical tests, or from cytological reports
on smears.SEX DEPENDENCE OF HUMAN INTRACRANIAL GLIOMATA
TABLE I.-Number and Incidence (per 100,000) of Intracranial Gliomata in
Adults (1961-1970)
Histology No histology
Male Female Male
No. Inc. No. Inc. No. Inc.
15 1 7 11 1.2 3 0 3
15 1 7 13 1-5 8 0 9
15 1 8 13 1 6 7 0 8
21 2 6 21 2 5 11 1 4
31 3-5 23 2 5 11 1 2
50 6 3 33 3 9 16 2 0
54 6 3 47 5.1 33 3 9
67 8 3 50 5 6 28 3 5
80 11 6 50 6*0 33 4 8
45 9 0 30 4 1 22 4.4
19 5 6 10 1 7 12 3 5
5 2 4 3 0 7 2 1.0
0 0 3 1P2 1 1.0
0 0 0 0 1 2 3
417 4.8 307 3 1 188 2.2
Female
No. Inc.
8 0 8
4 05
8 1-0
9 1.1
15 1 6
11 1 3
17 1 8
24 2 7
25 3 0
19 2 6
6 1-0
4 1-0
2 0 8
2 1 7
154 1.5
All tumours
Male Female
No. Inc. No. Inc.
18
23
22
32
42
66
87
95
113
67
31
7
1
1
605
2 0
2 6
2 6
4 0
4 7
8 3
10-2
11 8
16 4
13 4
9.1
3-4
1.0
2 3
7 0
19
17
21
30
38
44
64
74
75
49
16
7
5
2
461
2 0
2-0
2-6
3 6
4 1
5 2
6 9
8 3
9 0
6 7
2 7
1-7
2-0
1 7
4 6
Peak incidence in bold type.
Table gives the total number of tumours diagnosed for each age group over the 10-year period 1961-70,
plus the incidence per 100,000 of the population per year.
The types of histologically proven tumour
included in this survey were malignant epen-
dymomata, astrocytomata, oligendroglio-
mata, glioblastomata and medulloblasto-
mata.
Annual tumour incidence rates per 100,000
of the population for each quinquennium of
life were calculated, based on the estimated
population (2,831,384) in the same region for
1966.
RESULTS
The number and incidence of intra-
cerebral tumours recorded in male and
female adults, for each quinquennium of
life over the period 1961-70, are given in
Table I. The figures for histologically
proven and non-histologically proven glio-
mata were examined, and they are tabu-
lated separately. For each age group, the
proportion of tumours whose diagnosis
was confirmed histologically would appear
to be similar, as was the age/sex distri-
bution in the 2 groups. So, in further
analyses, both sets of figures were com-
bined (Table I).
The total number of tumours recorded
in adults over the 10-year period 1961-70
was found to be higher in males; 4 male
cases were reported for every 3 female
cases. This male-to-female ratio forintra-
cranial gliomata is not a true estimate,
because of the higher number of adult
females in the total population at risk,
the disparity increasing with age. When
the annual tumour incidence is expressed
relative to 100,000 of the population, the
sex ratio was found to be 3: 2. The pat-
tern of tumour incidence (per 100,000) in
the age group 20-44 years, whileincreasing
slowly with age, was similar in males and
females. Tumour incidence continued to
rise in the age group 45-64 years, although
in this case the incidence was higher in
males. A peak incidence was recorded in
both sexes in the age group 60-64 years.
After the age of65 years, tumourincidence
falls rapidly in both males and females,
and is at a level comparable with that in
the 20-24-year-old age group after the
age of 80 (Fig.).
The gliomata represent approximately
12% of all childhood malignancies regis-
tered in the Mersey Regional Cancer
Registry in the period 1961-70. As in
adults there is a predominance of intra-
cranial gliomata in males (Table II). The
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FIG.-Variation in gliomata incidence/year (per 100,000 of the population) with age, for male and
female adults (Liverpool area 1961-70).
incidence rates, again expressed per
100,000 of the population, indicate a sex
ratio of 3: 2, the same as that reported
for adults. Thepeakincidence oftumours
in children was found in the second 5
years of life.
DISCUSSION
The age and sex distribution of the
1223 cases of intracranial gliomata ana-
lysed in this study provide several inter-
esting points for comparison, both with
previously reported series of human cases
and with experimentally induced gliomata
in the rat.
The ratios of male to female tumours
in adults reported here, of 4 males to
every 3 females, and 3: 2 if tumour inci-
dence rates in the 2 sexes are compared,
are in agreement with those reported by
Penman and Smith (1954) for cases
examined over the period 1937-47, and
Guomundsson (1970) over the period
1954-63.
These values are, however, somewhat
lower than the ratio of I8: 1 or even
TABLE II.-Number and Incidence (per 100,000) ofIntracranial Gliomata in
Children (1961-70)
Histology
Male Female
r t
No. InIc. No. Inc.
19 1-4 9 0-7
18 1-5 7 0 6
13 1-2 9 0*9
13 1.1 8 0 7
No histology
Male Female
No. Inc. No. Inc.
11 0 8 4 0 3
6 0 5 8 0 7
8 0 7 9 0 9
10 0 9 5 0 5
All tumours
A
Male Female
No. Inc. No. Inc.
30 2 2 13 1.0
24 2-0 15 1-3
21 1-9 18 1-8
23 2-0 13 1-2
All ages 63 1-3 33 0 7 35 0 7 26 0-6 98 2-1 59 1-3
Table gives the total number of tumours diagnosed for each group over the 10-year period 1961-70 plus
the incidence per 100,000 of the population per year.
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3: 1 quoted by other authors (Cushing,
1930; Netsky, August and Fowler, 1950)
but both these studies were based on a
rather limited number of cases. In the
small number of cases (55) examined by
Percy et al. (1972), no sex difference for
gliomata was found. It is of interest to
note that cumulative incidence rates for
cerebral gliomata in rats, induced by a
locally implanted chemical carcinogen
(Hopewell, 1975), provided a similar
ratio of male to female tumours (4: 3)
to that found in man, although only a
limited number of animals was used.
The primary aim of this investigation
was to determine, in a large well-docu-
mented series of patients, the age-related
incidence of intracranial gliomata in male
and female adults. Two important
changes in age-related tumour incidence
were observed which, experimental find-
ings suggest (Hopewell, 1975) may be
related to a natural decline in sex hormone
precursor levels.
The first of these changes occurs
during the age period 45-64 years, when
the increase in incidence is less for females
than for males. The second change
occurs from the age 65 onwards, when
tumour incidence declines rapidly. In the
age group 20-44 years the incidence of
gliomata was similar in both sexes.
Both these findings are broadly con-
sistent with previously published results.
We have noted elsewhere (Hopewell and
Wright, 1969) that the cases presented by
Penman and Smith (1954) provide evi-
dence for the appearance of a sex-related
incidence during middle life, although at a
slightly younger age than in the present
series. A decline in overall incidence in
old age has also been reported for primary
brain tumours (Cohen and Modan, 1968;
Waterhouse, 1974; Guomundsson, 1970).
This group of tumours includes meningio-
mas, benign and unspecified central ner-
vous system tumours, in addition to
malignant gliomata, the latter group
forming from 38 to 58% of all primary
brain tumours (Guomundsson, 1970).
There has only been one report, based on
55 cases, in which the incidence of glio-
mata continued to increase with age
(Percy etal., 1972). These authors believed
this to be due to the fact that they had
complete postmortem records, and this
had enabled them to ascertain the full
incidence of gliomata. However, it is
the experience oflong-serving pathologists
in the region covered bythepresent study,
that brain tumours are very rarely found
at postmortem examination when none
were suspected during the life of the
patient. Under-ascertainment of tumours
is therefore unlikely to explain the decline
in incidence that we have observed.
Our hypothesis is that the sex differ-
ence in incidence from 45 onwards, and
the decline in tumour incidence after the
age of 65, are both related to changes in
the levels of sex hormones and their
precursors. The former coincides with the
menopausal changes in oestrogen levels
in women, and the latter with a fall in
testosterone levels and testicular activity
in males (Vermeulen, Rubens and Ver-
donck, 1972; Rubens, Dhont and Ver-
meulen, 1974). Whether changes in hor-
mone levels can explain the same rapid
decline in tumour incidence in females
after the age of 65 is unknown.
Evidence that hormonal changes can
affect the incidence ofgliomata is provided
by experimental findings in the rat. The
observation that the surgical removal of
the gonads reduces the incidence of
gliomata induced by intracerebrally im-
planted carcinogens, and that this effect
is not reversed by the s.c. implantation
of testosterone, has led to the suggestion
that this is likely to be due to deficiency
of a common precursor of the ovarian and
testicular hormones (Hopewell, 1975).
Castration would also appear to cause the
regression of some actively growing trans-
planted gliomata in the rat (Avtsyn and
Yablonoskayan, 1964). Whether a decline
in oestrogen precursors explains the ob-
served difference in time-related tumour
incidence in chemically induced gliomata
in hormonally normal male and female
rats (Hopewell, 1975) is uncertain, for
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although the fertility of female rats is
known to decline rapidly in animals over
one year ofage,no information is available
as to the oestrogen levels in ageing rats.
A sex dependence has also been
reported in childhood gliomata (Bodian
and Lawson, 1952) with a ratio of 3
males to 2 females. This finding is in
agreement with the present study. Our
results, which suggest that the peak
incidence in children occurs in the second
5 years of life, agreed with those of other
authors (Penman and Smith, 1954; Wil-
son, 1975), although the number of cases
recorded in the present study was small.
Although changes in hormone levels
may provide an explanation for the sex
difference observed in the incidence of
gliomata in adults, it is unlikely to provide
an explanation for the sex difference
observed in children. The difference in
the distribution of the histological types,
and site of intracranial tumours in chil-
dren as compared with adults, may
provide a partial explanation. Medullo-
blastoma and ependymomata, which are
common in children (Penman and Smith,
1954; Marsden and Steward, 1968) but
rare in adults, have been shown to exhibit
a marked sex dependence with a sex ratio
(male: female) of 1-7: 1 and 1-47: 1
respectively (Steward, Lennox and San-
ders, 1973). The other histological types
ofgliomata in children, which in the adult
show marked sex differences, exhibit
little or no sex dependence in children
(Penman and Smith, 1954; Steward,
Lennox and Sanders, 1973). Why medul-
loblastoma and ependymomata should be
more common in children is unknown.
The authors are grateful to Dr Gerald
Draper for his many helpful comments
during the preparation ofthis manuscript.
The experimental work which provided
the foundation for this study was sup-
ported bygrants from the Cancer Research
Campaign, The National Fund for Re-
search into Crippling Disease and the
Medical Research Council. The Research
Institute gratefully acknowledges support
from the Oxfordshire Area Health Auth-
ority (Teaching). In addition we would
acknowledge the help given by the staff
ofthe Clinical Research Unit, the Regional
Cancer Registry (M.R.C.R.O.) and the
Computer Centre, Mersey Regional Health
Authority.
REFERENCES
AVTSYN, A. P. & YABLONOVSKAYAN, L. Y. (1964)
Effects of Disturbances in the Hormonal States
of Experimental Brain Tumours. Acta Un. int.
Cancr., 20, 1519.
BODIAN, M. & LAWSON, D. (1952) The Intracranial
Neoplastic Diseases of Children. Br. J. Surg.,
40, 368.
COHEN, A. & MODAN, B. (1968) Some Epidemio-
logical Aspects of Neoplastic Diseases in Israel.
Immigrant Population III Brain Tumours.
Cancer, N.Y., 22, 1323.
CUSHING, H. (1930) Experience with the Cerebellar
Medulloblastoma; a Critical Review. Acta Path.
Microbiol. Scand., 7, 1.
GUOMUNDSSON, K. R. (1970) A Surveyof Tumoursof
the Central Nervous System in Iceland during the
10 Year Period 1954-63. Acta Neurol. Scand.,
46, 538.
HOPEWELL, J. W. (1975) The Hormone Dependence
of Experimentally Induced Gliomas in the Rat.
Neuropath. app. Neurobiol., 1, 141.
HOPEWELL, J. W. & WRIGHT, E. A. (1969) The
Importance of Implantation Site in Cerebral
Carcinogenesis in Rats. Cancer Res., 29, 1927.
MARSDEN, H. B. & STEWARD, J. K. (1968) Gliomas
and Other Intracranial Tumours. Recent Results
in Cancer Research, 13, 86.
NETSKY, M. G., AUGUST, B. & FOWLER, W. (1950)
The Longevity of Patients with Glioblastoma
Multiforme. J. Neurosurg., 7, 261.
PENMAN, J. & SMITH, M. C. (1954) Intracranial
Gliomata. Medical Research Council Special
Report, No. 284.
PERCY, A. K., ELVEBACK, L. R., OKAZAKI, H. &
KURLAND, L. T. (1972) Neoplasms of the Central
Nervous System: Epidemiological Considerations.
Neurology, 22, 40.
RUBENS, R., DHONT, M. & VERMEULEN, A. (1974)
Further Studies on Leydig Cell in Old Age.
J. clin. endocrin. Meth., 39, 40.
SHELINE, G. E. (1975) Radiation Therapy of
Tumours of the Central Nervous System in
Childhood. Cancer, N.Y., 35, 957.
STEWARD, A. M., LENNOX, E. L. & SANDERS, B. M.
(1973) Group Characteristics of Children with
Cerebral and Spinal Cord Tumours. Br. J.
Cancer, 28, 568.
VERMEULEN, A., RUBENS, R. & VERDONCK, L.
(1972) Testosterone Secretion and Metabolism in
Male Senescence. J. clin. endocrin. Meth., 34, 730.
WATERHOUSE, J. A. H. (1974) Cancer Handbooks of
Epidemiology and Prognosis. London: Churchill
Livingstone.
WILLIS, R. A. (1953) Pathology of tumours, 2nd ed.
London: Butterworth and Co. Ltd.
WILSON, C. B. (1975) Diagnosis and Surgical Treat-
ment ofChildhood Brain Tumours. Cancer, N.Y.,
35, 950.